Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 4
Submit an article Journal homepage
72
Views
9
CrossRef citations to date
0
Altmetric
Commentary

Denileukin diftitox and vision loss

Dr J. B. Ruddle Royal Victorian Eye and Ear Hospital, East Melbourne, AustraliaCorrespondence[email protected]
&
H. Miles Prince Peter MacCallum Cancer Centre and University of Melbourne, Australia
Pages 655-656 | Published online: 01 Jul 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

H Miles Prince & Kate M Newland. (2014) Denileukin diftitox for the treatment of cutaneous T-cell lymphoma. Expert Opinion on Orphan Drugs 2:6, pages 625-634.
Read now
Grant T. Liu & Ellen J. Kim. (2008) Response to correspondence: Denileukin diftitox vision loss not due to posterior ischemic optic neuropathy. Leukemia & Lymphoma 49:2, pages 372-372.
Read now
Martin Lubow, Deborah M. Grzybowski & Hamdy Awad. (2008) Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy. Leukemia & Lymphoma 49:2, pages 370-371.
Read now

Articles from other publishers (6)

. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 863 .
Wajiha J. Kheir, Matthew C. Sniegowski, Tarek El-Sawy, Alexa Li & Bita Esmaeli. (2014) Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy. Survey of Ophthalmology 59:5, pages 493-502.
Crossref
Catherine Y. Liu, Jasmine H. Francis, Scott E. Brodie, Brian Marr, Jose S. Pulido, Michael F. Marmor & David H. Abramson. (2014) RETINAL TOXICITIES OF CANCER THERAPY DRUGS. Retina 34:7, pages 1261-1280.
Crossref
Rodrigo Vazquez-Lombardi, Brendan Roome & Daniel Christ. (2013) Molecular Engineering of Therapeutic Cytokines. Antibodies 2:4, pages 426-451.
Crossref
Haydn T. KissickDemelza J. IrelandManfred W. Beilharz. (2009) Combined Intratumoral Regulatory T-Cell Depletion and Transforming Growth Factor-β Neutralization Induces Regression of Established AE17 Murine Mesothelioma Tumors. Journal of Interferon & Cytokine Research 29:4, pages 209-216.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.